The article talks about a company called Goldman Sachs and another one called AbbVie. They both do different things, but they are important in the world of business. Some people who know a lot about these companies think they will do well in the future, so they tell other people to buy their stocks. This means more people want to own a part of these companies and their value goes up. The article also talks about a big chipmaker company called Taiwan Semiconductor Manufacturing, but it didn't do as well recently. Read from source...

1. The title is misleading and sensationalized, as it implies that CNBC's "Final Trades" are the only or most important ones to consider for investors. There are many other sources of financial advice and analysis available, and investors should do their own research and due diligence before making any decisions based on someone else's opinion.

Positive

Based on my analysis of the article, I believe it has a positive sentiment overall. The reasons for this are as follows:

1. William Blair analyst Tim Lugo upgraded AbbVie from Market Perform to Outperform, indicating a bullish outlook on the company's growth prospects.
2. Goldman Sachs is reportedly seeking new talent for its asset and wealth management divisions, suggesting an expansion in these sectors which could lead to higher revenues and profits in the future.